BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 71 filers reported holding BIODELIVERY SCIENCES INTL IN in Q4 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $8,872,000 | -22.0% | 2,034,900 | -32.2% | 0.18% | -54.4% |
| Q1 2020 | $11,370,000 | -40.0% | 3,000,000 | 0.0% | 0.38% | -31.1% |
| Q4 2019 | $18,960,000 | -39.3% | 3,000,000 | -59.6% | 0.56% | -57.3% |
| Q3 2019 | $31,259,000 | -9.5% | 7,424,867 | 0.0% | 1.30% | +9.2% |
| Q2 2019 | $34,526,000 | -12.3% | 7,424,867 | 0.0% | 1.19% | -29.8% |
| Q1 2019 | $39,352,000 | +125.1% | 7,424,867 | +57.1% | 1.70% | +62.9% |
| Q4 2018 | $17,483,000 | +14.8% | 4,725,000 | -13.1% | 1.04% | +49.5% |
| Q3 2018 | $15,226,000 | -5.1% | 5,437,779 | 0.0% | 0.70% | +13.1% |
| Q2 2018 | $16,041,000 | +31.1% | 5,437,779 | 0.0% | 0.62% | +5.8% |
| Q1 2018 | $12,235,000 | +67.9% | 5,437,779 | +120.2% | 0.58% | +23.7% |
| Q4 2017 | $7,285,000 | +546.4% | 2,469,488 | +283.4% | 0.47% | +107.0% |
| Q4 2016 | $1,127,000 | – | 644,176 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,595,855 | $10,929,000 | 10.61% |
| Broadfin Capital, LLC | 4,300,066 | $18,103,000 | 3.35% |
| 1492 Capital Management LLC | 778,483 | $3,277,000 | 3.20% |
| Avoro Capital Advisors LLC | 7,424,867 | $31,259,000 | 1.30% |
| Rubric Capital Management LP | 2,590,288 | $10,905,000 | 1.00% |
| Eversept Partners, LP | 708,020 | $2,980,764 | 0.92% |
| KNOTT DAVID M | 517,507 | $2,179,000 | 0.92% |
| Nantahala Capital Management | 4,846,167 | $20,402,000 | 0.76% |
| Grandeur Peak Global Advisors, LLC | 1,180,075 | $4,968,000 | 0.54% |
| EMERALD ADVISERS, LLC | 2,084,685 | $8,777,000 | 0.41% |